HK Stock Market Move | MIRXES-B(02629) rose by over 3% recently following the successful bid for a 26-year gastric cancer screening and early intervention project in Lixi District.

MIRXES-B (02629) rose by more than 3%, as of the deadline, it rose by 1.18% to 15.41 Hong Kong dollars, with a turnover of 1144.23 million Hong Kong dollars. On the news front, on March 3, MIRXES-B announced that on March 3, 2026, the company successfully won the bid for the 2026 Gastric Cancer Screening and Early Intervention Project in Lianxi District. This is the company's first public health cancer early screening project and its first government procurement project in China, marking the official entry of its miRNA liquid biopsy technology into the public health system, laying a key foundation for the large-scale implementation of gastric cancer early screening. Winning this project also reflects the company's vision of "intercepting cancer in the early stage". The implementation of this project will help Lianxi District build a closed-loop gastric cancer prevention and control system based on the principles of "screening-diagnosis-intervention-follow-up", and is expected to reduce the incidence and mortality of gastric cancer in the region. This project is also an important milestone in the commercialization of the company's work, supporting the company in transforming its research and development capabilities into positive public health applications. It is expected to further solidify its leading position in the field of cancer early screening, bringing affordable early cancer detection services to more people.